Cipla’s arm completes allocation of shares to FIL Capital Investments

13 Apr 2016 Evaluate

Cipla’s subsidiary -- Cipla Health has allotted shares to FIL Capital Investments (Mauritius) II and consequently, the transaction has now been completed. The company’s board at its meeting held on April 12, 2016, has approved for the same.

Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 150 countries. Its portfolio includes 1500 plus products across therapeutic categories with one quality standard globally.

Cipla Share Price

1391.20 -6.75 (-0.48%)
19-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.55
Dr. Reddys Lab 1166.45
Cipla 1391.20
Zydus Lifesciences 881.10
Lupin 2178.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×